Bonghee Lee, Republic of Korea
Bonghee's research interests include "Functional proteomics and systems biology for stem cell biology".
Fei Fang, China
Fei's work focus on the development of cutting-edge mass spectrometry based proteomic technologies and elucidating the structure-functions of native macromolecular assemblies.
Hosseini Salekdeh, Iran
Hosseini's research includes the identification of cell surface markers for purification of human embryonic stem cells-derived progenitor cells for cell therapy applications. I also utilize proteomics to identify biomarkers associated to disease or major phenotypes/traits.
Laura Dagley, Australia
Laura's research focuses on blood-based biomarker discovery for various diseases including acute rheumatic fever, a disease endemic in Australian Indigenous populations. Laura has also received NH&MRC funding to study IL-15 and TGF-beta signalling crosstalk in the context of cancer and immunotherapy.
Rommel Mathias, Australia
The Mathias Lab studies exosome and extracellular vesicle biogensis, and the molecular hijacking of these pathways by viruses during infection.
Shamshad Zarina, Pakistan
Shamshad's work is focused on cancer proteomics that deals with identification of potential biomarkers in relation to diagnosis, prognosis and therapeutics response. Her work also uses bioinformatics tools coupled with wet lab experiments for drug destining.
Michelle Hill, Australia
Michelle leads a multidisciplinary program in translational research focussing on molecular diagnostics and systems biomedicine incorporating multi- and meta- omics as well as molecular cell biology techniques.
Subhra Chakraborty, India
Subhra's research focuses on understanding molecular mechanism, proteomic pathways, and metabolic fingerprints involved in nutrient, disease-response and immunity using organeller and quantitative proteomics and system biology in the area of Nutrition and Food.
Henry Lam, China
Henry Lam is Associate Professor in the Department of Chemical and Biological Engineering at the Hong Kong University of Science and Technology (HKUST).
Tadashi Yamamoto, Japan
Adhar Al Zaabi, Oman
Adhari’s research is on cancer proteomics and multi-omics studies that mainly deals with identifying potential biomarkers that aid to improve cancer early detection, diagnosis and treatment response.
Concha Gil, Spain
The main objective of Concha's research is to search novel biomarker and vaccine candidates for invasive candidiasis and to monitor the activation of signaling pathways in innate immune cells interacting with Candida cells.
Elena Ponomarenko, Russia
Elena's research focuses on post-genome data analytics, automated data-mining and text-processing. Co-PI in the International Chromosome-Centric Human Proteome Project.
Jochen Schwenk, Sweden
Jochen's research focusses on multiplexed affinity proteomics methods for studying the human plasma proteome.
Magnus Palmblad, The Netherlands
Magnus’s research concerns new methods and principles for integrating large-scale biological data, including from mass spectrometry, across space, time and omics domains using scientific workflows of semantically annotated software components.
Nicolai Bache, Denmark
Nicolai's leads the application development together with leading experts and spearheads novel low-flow LC technology innovations tailored for clinical applications.
Paola Roncada, Italy
Paola is currently involved in different national and international programs that promote proteomics in field of nutrition, veterinary infectious disease, animal welfare and food safety in the context ‘One Health’ approach.Her focus research areas are in the field of proteomics applied to microbes, milk, food and public health, zoonoses.
Yves Vandenbrouck, France
Yves's research focuses on the design of in silico approaches for “omics” data analysis and biological knowledge extraction. In the context of HUPO, he actively contributes to the Human Proteome Project for the French part and received the C-HPP investigator award for excellent achievements in 2016.
Ruth Birner-Grünberger, Austria
Ruth Birner-Grüenberger, Medical University of Graz, Austria: My research group employs proteomics and metabolomics to study lipid and energy metabolism and lipid signaling in health and disease.
Manfred Raida, Germany
Robert Moritz, USA (Chair)
Rob’s lab develops and applies novel proteomics technologies to systems biology focused research involving biomarker discovery, protein modulation by post-translational modifications, large scale bioinformatic efforts and resources for the entire human proteome, and translational drug discovery efforts in wellness, disease, and infectious microbes.
W. Andy Tao, USA
Andy's lab focuses on developing novel chemistry to solve important biological questions, with a special emphasis on characterizing proteins involved in signaling transduction and diseases using state-of-the-art analytical tools.
Birgit Schilling, USA
Birgit's research focuses on aging and she interested in translational aspects and of aging and age–related diseases, as well as biomarker development. Additional interests are in monitoring dynamic changes of posttranslational modifications with changes in metabolism, nutrition and/or disease conditions.
Catherine Fenselau, USA
Catherine has contributed to proteomic science since 1998, including the introduction of O-18 labeling for comparative proteomics (Anal.Chem 2001), identification of a binding hotspot in metallothionein (Drug Metab. Distrib. 2000), characterization of glycoproteins on the surface of exosomes (J.Prot.Res. 2017), and successful top-down analysis of branched proteins (J.Mass Spectrom. 2016; Anal.Chem. 2018).
Hannes Rost, Canada
Hanne's research explores the capability novel mass spectrometric methods to obtain highly quantitative proteomics and metabolomics data matrices and use these quantitative data to address questions in systems biology and personalized medicine.
Pierre Thibault, Canada
Pierre's research program combines mass spectrometry-based proteomics and protein chemistry to gain further insights into the molecular mechanisms and post-translational modifications that regulate the function and translocation of proteins involved in immunity and signaling in cancer cells.
Ralph Bradshaw, USA
Ralph's research interests are in intracellular signaling and accompanying post-translational modifications. He is also interested in the co- and post-translational N-terminal processing of proteins.
Reinhild Kappelhoff, Canada
Reinhild is the Protease Degradomics Researcher, Lab manager and Sustainability Coordinator at the Centre for Blood Research at the University of British Columbia.
Sergio Encarnacion-Guevara, Mexico
Sergio's major research interests of his lab include cancer proteomics, tumoral dynamics, quantitative proteomics and posttranslational modifications of proteins, particularly phosphorylation and lysine acetylation stoichiometry.
Susan Weintraub, USA
Susan directs a mass spectrometry core facility for proteomics and metabolomics at the University of Texas Health Science Center at San Antonio and supports a wide range of projects, particularly on cancer, diabetes, and aging.
Tatiane De Rossi, Brazil
Tatiane is a doctor and researcher from Brazilian Biosciences National Laboratory, searching for saliva protein candidates as oral cancer markers.
Yansheng Liu, USA
Yansheng's research group at Yale aims to contribute to the development of Data independent acquisition mass spectrometry and other proteomic techniques, as well as their applications in cancer biology and systems biology studies. Dr. Liu's group is especially interested in revealing the impact of genetics at the protein dosage and turnover levels.